ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 26 filers reported holding ASTRAZENECA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $762,527 | -11.2% | 11,260 | -6.2% | 0.04% | -13.3% |
| Q2 2023 | $859,055 | +7.8% | 12,003 | +4.6% | 0.04% | -6.2% |
| Q1 2023 | $796,688 | -8.9% | 11,478 | -11.0% | 0.05% | -9.4% |
| Q4 2022 | $874,756 | +20.8% | 12,902 | -2.3% | 0.05% | +6.0% |
| Q3 2022 | $724,000 | -15.3% | 13,204 | +1.8% | 0.05% | +19.0% |
| Q2 2022 | $855,000 | -3.8% | 12,972 | -3.3% | 0.04% | +10.5% |
| Q1 2022 | $889,000 | +7.2% | 13,412 | -5.9% | 0.04% | +18.8% |
| Q4 2021 | $829,000 | +11.3% | 14,247 | +14.0% | 0.03% | +10.3% |
| Q3 2021 | $745,000 | -1.5% | 12,493 | +0.4% | 0.03% | 0.0% |
| Q2 2021 | $756,000 | +173.9% | 12,446 | +139.2% | 0.03% | +262.5% |
| Q1 2021 | $276,000 | -9.2% | 5,203 | -24.8% | 0.01% | -33.3% |
| Q4 2020 | $304,000 | +81.0% | 6,917 | +127.5% | 0.01% | +33.3% |
| Q3 2020 | $168,000 | +32.3% | 3,040 | +25.9% | 0.01% | +28.6% |
| Q2 2020 | $127,000 | +9.5% | 2,415 | -12.1% | 0.01% | -12.5% |
| Q1 2020 | $116,000 | -27.0% | 2,747 | -13.1% | 0.01% | 0.0% |
| Q4 2019 | $159,000 | +17.8% | 3,162 | +5.5% | 0.01% | 0.0% |
| Q3 2019 | $135,000 | +9.8% | 2,997 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $123,000 | +10.8% | 2,997 | +9.1% | 0.01% | +14.3% |
| Q1 2019 | $111,000 | +22.0% | 2,747 | +13.7% | 0.01% | 0.0% |
| Q4 2018 | $91,000 | -10.8% | 2,415 | -7.1% | 0.01% | 0.0% |
| Q3 2018 | $102,000 | -1.0% | 2,599 | -11.4% | 0.01% | -12.5% |
| Q2 2018 | $103,000 | +1.0% | 2,935 | 0.0% | 0.01% | -11.1% |
| Q1 2018 | $102,000 | -25.0% | 2,935 | -25.3% | 0.01% | -25.0% |
| Q4 2017 | $136,000 | +24.8% | 3,928 | +21.6% | 0.01% | +9.1% |
| Q3 2017 | $109,000 | +10.1% | 3,231 | +10.2% | 0.01% | +10.0% |
| Q2 2017 | $99,000 | -25.0% | 2,931 | -31.2% | 0.01% | -28.6% |
| Q1 2017 | $132,000 | -94.9% | 4,260 | -95.5% | 0.01% | -95.9% |
| Q4 2016 | $2,599,000 | +59.8% | 95,143 | +93.1% | 0.34% | +56.6% |
| Q3 2016 | $1,626,000 | +187.8% | 49,282 | +165.2% | 0.22% | +167.1% |
| Q2 2016 | $565,000 | +88.3% | 18,582 | +74.8% | 0.08% | +78.3% |
| Q1 2016 | $300,000 | – | 10,631 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |